Moxie Industries, Anaheim, said final approval has...
- Share via
Moxie Industries, Anaheim, said final approval has been reached on the terms of an agreement and plan of merger and reorganization with SPI Pharmaceuticals, Costa Mesa. SPI currently owns about 84% of the 10.5 million outstanding shares of Moxie’s common stock. Under the merger agreement, each share of Moxie common stock would be converted to the right to receive 50 cents worth of SPI common stock, or 41 cents in cash. Moxie manufactures vitamins and food supplements.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.